Pathological Foundations of Skeletal Muscle After Volumetric Muscle Loss and Targets For Rehabilitation
体积肌丢失后骨骼肌的病理学基础和康复目标
基本信息
- 批准号:10364333
- 负责人:
- 金额:$ 48.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:Activities of Daily LivingAcuteAddressAmputationAxotomyBiomedical TechnologyBypassChemicalsChronicClinicClinicalCoupledCuesDenervationEffectivenessEnvironmentExerciseFailureFatty acid glycerol estersFoundationsFunctional disorderGuidelinesImpairmentIndividualInjuryKnowledgeMechanicsMedical Care CostsMetabolicMetabolic syndromeMetabolismMitochondriaModalityModelingMotorMotor NeuronsMovementMuscleMuscle FibersMuscle functionMuscular DystrophiesMyopathyNatural regenerationNeuromuscular JunctionOrthopedicsOutcomePassive Range of Motion functionPathologicPathologyPatientsPhysical MedicinePhysical activityPhysiologicalPhysiologyPopulationPropertyPublishingRecovery of FunctionRegenerative MedicineRegenerative capacityRehabilitation OutcomeRehabilitation therapyResearchSignal PathwaySignal TransductionSkeletal MuscleSourceTechnologyTestingTissuesWorkclinical carecomorbiditydaily functioningevidence baseexercise trainingfunctional disabilityfunctional improvementfunctional outcomesfunctional restorationimprovedinjuredlimb injurymitochondrial dysfunctionmuscle graftsmuscle physiologynerve supplyneuromuscularpatient populationpresynapticrecruitregeneration potentialregenerativeregenerative rehabilitationrehabilitation strategyrepairedresponsesarcopeniaskeletal muscle plasticityskeletal muscle wastingsoft tissuestandard of caretreatment guidelinestwo photon microscopyvolumetric muscle loss
项目摘要
Abstract
Orthopaedic extremity trauma is a major problem resulting in both long-term functional disability and substantial
medical cost in various populations. One such injury is volumetric muscle loss (VML), which is clinically identified
as a chronic and irrecoverable loss of skeletal muscle tissue resulting in functional impairments. VML is coupled
with clinical outcomes related to long-term dysfunction, reduced mobility and physical activity, co-morbidities,
and often delayed amputation. Additionally, a major problem identified in the clinic is an inability to respond to
rehabilitation; even prolonged and intensive rehabilitation has not been able to ameliorate functional
impairments. The fundamental principles of rehabilitation revolve around the plasticity of skeletal muscle, or the
ability to adapt to perceived mechanical or chemical cues in order to improve its functional capacity and
efficiency. We hypothesize that pathophysiologic limitations in the muscle remaining after VML injury relate to
lack of endogenous regenerative ability, such as improvements in whole-body metabolism. We believe that for
the VML-injured patient, pathophysiologic changes to the remaining muscle and co-morbidities to injury, such as
metabolic inflexibility, could be as much of a problem as the primary loss of contractile tissue. To date, a
comprehensive understanding of the natural sequela of injury is absent, specifically, an understanding of the
muscle remaining after injury and how the devastating pathophysiologic changes impact the inherent properties
of muscle. Our central hypothesis is that muscle dysfunction, muscle fiber and whole-body metabolic
insufficiency, and neuromuscular deficiency create a hostile cellular environment in the remaining muscle that
mitigates muscle plasticity and blunts the effectiveness of regenerative rehabilitation. We propose three specific
aims to address these hypotheses: 1) To establish signaling mechanisms of diminished innervation in the
remaining muscle after VML; 2) To identify cellular mechanisms of oxidative adaptation in the remaining muscle
after VML; and 3) To determine the contribution of the remaining muscle to whole-body metabolism after VML
to improve regenerative rehabilitation. The results of the proposed studies will define cellular mechanisms that
contribute to the finite adaptive and regenerative capacity of the remaining muscle after VML and we expect
these results could transformative to clinical care for VML-injured patients both acutely and chronically.
Additionally, fundamental understanding of the lack of regenerative potential in skeletal muscle could be
transformative to other conditions of skeletal muscle such as muscular dystrophies, non-dystrophic myopathies,
and sarcopenia.
抽象的
骨科肢体创伤是导致长期功能残疾和严重伤害的一个主要问题。
不同人群的医疗费用。其中一种损伤是体积肌肉损失(VML),这是临床上发现的
作为骨骼肌组织的慢性且不可恢复的损失,导致功能障碍。 VML耦合
与长期功能障碍、活动能力和体力活动减少、合并症相关的临床结果,
并且经常延迟截肢。此外,诊所发现的一个主要问题是无法应对
康复;即使长期和强化的康复也无法改善功能
损伤。康复的基本原则围绕骨骼肌的可塑性,或者说
适应感知的机械或化学线索的能力,以提高其功能能力和
效率。我们假设 VML 损伤后剩余肌肉的病理生理学限制与
缺乏内源性再生能力,例如全身新陈代谢的改善。我们相信,对于
VML 损伤的患者,剩余肌肉的病理生理变化以及损伤的并发症,例如
代谢不灵活可能与收缩组织的主要丧失一样严重。迄今为止,一个
缺乏对伤害自然后遗症的全面了解,特别是对
受伤后剩余的肌肉以及破坏性的病理生理变化如何影响其固有特性
的肌肉。我们的中心假设是肌肉功能障碍、肌纤维和全身代谢
不足和神经肌肉缺陷在剩余的肌肉中创造了一个敌对的细胞环境,
减轻肌肉可塑性并削弱再生康复的有效性。我们提出三项具体建议
旨在解决这些假设:1)建立神经支配减弱的信号机制
VML 后剩余的肌肉; 2) 确定剩余肌肉氧化适应的细胞机制
VML之后; 3) 确定 VML 后剩余肌肉对全身代谢的贡献
以改善再生康复。拟议研究的结果将定义细胞机制
有助于 VML 后剩余肌肉的有限适应和再生能力,我们预计
这些结果可能会改变 VML 急性和慢性损伤患者的临床护理。
此外,对骨骼肌缺乏再生潜力的基本理解可能是
转化为骨骼肌的其他病症,例如肌营养不良症、非营养不良性肌病、
和肌肉减少症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jarrod A Call其他文献
Jarrod A Call的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jarrod A Call', 18)}}的其他基金
Pathological Foundations of Skeletal Muscle After Volumetric Muscle Loss and Targets For Rehabilitation
体积肌丢失后骨骼肌的病理学基础和康复目标
- 批准号:
10597639 - 财政年份:2022
- 资助金额:
$ 48.6万 - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Next Generation Opto-GPCRs for Neuromodulatory Control
用于神经调节控制的下一代 Opto-GPCR
- 批准号:
10515612 - 财政年份:2023
- 资助金额:
$ 48.6万 - 项目类别:
Development and Validation of the Down Syndrome Regression Rating Scales
唐氏综合症回归评定量表的开发和验证
- 批准号:
10781052 - 财政年份:2023
- 资助金额:
$ 48.6万 - 项目类别:
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
翼腭窝 (PPF) 阻滞作为阿片类药物节省治疗动脉瘤性蛛网膜下腔出血的急性头痛
- 批准号:
10584712 - 财政年份:2023
- 资助金额:
$ 48.6万 - 项目类别:
Racial Differences in Hospital-Associated Disability and Acute and Post-Acute Care Physical Therapy Utilization
医院相关残疾以及急性和急性后护理物理治疗利用的种族差异
- 批准号:
10785500 - 财政年份:2023
- 资助金额:
$ 48.6万 - 项目类别:
The Protective and Pathologic Features of the EVD Survivor Immune System
埃博拉病毒病幸存者免疫系统的保护和病理特征
- 批准号:
10639583 - 财政年份:2023
- 资助金额:
$ 48.6万 - 项目类别: